All In MedTech

Device Trial Radar · NCT03379272

Comparison Of NeuroNaute Smart System to a Standard EleCTroencephalogram System in Hospital

CONNECT: Comparison Of NeuroNaute Smart System to a Standard EleCTroencephalogram System in Hospital

Last checked: Nov 19, 2026Latest source record: Nov 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Dec 20, 2020

Primary completion

Dec 20, 2020

Study completion Dec 20, 2020

Sponsor

Lead sponsor
BioSerenityNot on our public-company list
Sponsor type
Industry
Collaborators
Pitié-Salpêtrière Hospital
First posted
Dec 20, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The proposed study is designed to evaluate the performance of the Neuronaute in comparison with the gold standard EEG in patients with a regular appointment at the hospital. The design of this study is guided by two overriding factors : (i) epileptics disorders suspected or either (ii) epileptics already diagnosed. Volunteers will be asked to participate to this study. This study will enroll 35 outpatient subjects aged 18 to 85. Informed consent will be obtained from the patients, and assent from the subjects, prior to any form of assessment or intervention as part of the study. Patients will be submitted to the studied device record Neuronaute following by the gold standard EEG. A grid with all EEG activity recorded during the trial will be provided for evaluation after completion of the trial.

Conditions

  • Epilepsy

Interventions

  • GOLDSTANDARDDevice

    RECORDING WITH EEG GOLDSTANDARD

  • NEURONAUTEDevice

    RECORDING WITH NEURONAUTE

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Reproducibility of electroencephalographic signals interpretation recorded by the Neuronaute compared to the gold standard.Time frame: 1 year

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.